Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2022-01-03 | Amended | $11,626,000 | $8,455,000 | Equity Only | 06b | SEC link |
| 2021-03-30 | New | $3,171,000 | $3,171,000 | Equity Only | 06b | SEC link |
| 2017-07-20 | Amended | $9,227,000 | $1,917,000 | Equity Only | 06b | SEC link |
| 2017-06-27 | New | $7,310,000 | $7,310,000 | Equity Only | 06b | SEC link |
| 2016-12-08 | New | $1,973,000 | $1,973,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Isaac Blech | Director |
| Dr. Gerald D. Cagle | Director |
| Gerald Cagle | Director |
| Richard Chin, M.D. | Director |
| William Halden Conner | Director, Executive |
| Halden Conner | Director, Executive |
| Sanford J. Hillsberg | Director |
| Charles Lieser | Executive |
| Robert Ruffolo | Director |
| Robin Steel | Director |
| G. Michael Wall, Ph.D. | Executive |
| David Wohlberg | Director, Executive |
| Benjamin Yerxa | Director |